TriLink BioTechnologies Enters into Distribution Agreement with Sigma-Aldrich Corporation

Published: Jan 18, 2012

SAN DIEGO (January 18, 2012) - TriLink BioTechnologies Inc. (TriLink) announced that it has entered into a distribution agreement with Sigma-Aldrich to sell its CleanAmp™ dNTPs globally.

As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ dNTPs are an ideal complement to Sigma-Aldrich's product and service offerings. In developing CleanAmp™, TriLink applied their expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.

"TriLink is very pleased to have its innovative Hot Start PCR technology, CleanAmp™ dNTPs added to the line of PCR reagents offered by Sigma. CleanAmp™ dNTPs are a great addition to Sigma's portfolio and Sigma's global distribution channels will undoubtedly get this novel technology into more hands," stated TriLink's President and CEO, Richard Hogrefe, Ph.D.

About TriLink

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services in ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit their web site at www.trilinkbiotech.com.

Back to news